Company RLS Global AB (publ) Nasdaq Stockholm
Equities
SE0005190725
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 20-12-31 |
Director of Finance/CFO | 64 | 23-08-21 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 20-12-31 |
Susanne Olausson
CTO | Chief Tech/Sci/R&D Officer | 53 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 12-07-31 | |
Director/Board Member | 63 | 17-07-31 | |
Anders Edvell
BRD | Director/Board Member | 55 | 22-12-31 |
Roland Frösing
CEO | Chief Executive Officer | 64 | 20-12-31 |
Lars Johansson
CHM | Chairman | 58 | 22-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 79,874,705 | 41,780,367 ( 52.31 %) | 0 | 52.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |